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Glutaminase inhibition by methylguanidine and the consequence on
renal ammoniagenesis. f',/ A cquarone, A. Tizianello, G. Dc Ferrari,
M. Bruzzone, A. Papio, and G. Garibotto. Department of Internal
Medic/pie, ('hair of Medical Nephrology, University of Genoa. Sev-
eral nitrogenous compounds which increase in azotemic serum
have been shown to induce various biochemical defects in uremia.
Since our previous studies demonstrated that glutamine is not
utilized by the kidney for ammonia production in chronic renal
insufficiency, we studied the effect of urea, creatinine, and methyl-
guanidine on ammonia production from glutamine by acidotic
rat renal cortical slices. Results indicate that methylguanidine in-
duces a 40% inhibition on ammoniagenesis from glutamine (88 +
5.2 vs. 142 10.2 smole/90 min/g of body wt), whereas urea and
creatinine show no effect. In order to further investigate how such
inhibition takes place, we tested the direct effect of methyl-
guanidine on glutaminases in samples of homogenized renal
cortex taken from acidotic rats. There was a 40% inhibition of
phosphate-independent-glutaminase, whereas no significant inhibi-
tion of phosphate-dependent glutaminase was detected. Further-
more, the long-term administration of methylguanidine to acidotic
rats reduced ammonia production from glutamine by cortical slices
by 25%. Results here reported clearly demonstrate the inhibitory
effect of methylguanidine on phosphate-independerit-glutaminase,
the key enzyme for renal ammonia production, and stress the
importance of methylguanidine in uremic state.
Gastric secretion in uremia. F. Antonucci, P. Vezzadini, G. Bo-
flora, G. Cantarini, A. Adami, and U. Compiano. Ospedale Civile di
Treviso, Div/s/one Nefrologica, Università di Bologna, I C/mica
Med/ca and Osp. (ivile di Treviso, Centro di Gastroenterologia.
Basal and stimulated (pentagastrin, 6 sg/kg of body wt) gastric
secretion were studied in 61 patients on regular dialysis treatment
(RDT) and in 42 patients with chronic renal failure (CRF) in
conservative treatment. Gastric secretion pattern was similar in
both groups: hypersecretion (PAO/kg values over the normal
range) was noted in more than 50% of the patients. Their serum
gastrin showed elevated values: 205 + 188 pg/mI in undialyzed,
366 551 pg/mI in dialyzed patients. High incidence of hyper-
secretion may be due to the trophic action of chronically elevated
serum gastrin levels on gastric mucosa. Hyposecretionary patients
on RDT showed a mean serum gastrin level higher than normal
and hypersecretionary patients (P < 0.05). Serum gastrin response
to antral stimulation by meat extracts was larger arid higher in 21
nonhyposecretionary patients on RDT than in 17 controls with duo-
denal ulcers; however, in the first group the percent gastrin increase
response at the 15th minute was lower. This response may be
explained by an impaired renal inactivation of the gastrin or by a
lowered G cell reactivity to meat stimulation. In hypersecretionary
patients on RDT a significant relation was found between serum
gastrin and phosphate levels (P < 0.05). These patients showed a
significantly higher (P < 0.05) incidence of metastatic calcifica-
tions than normo or hyposecretionary dialyzed patients. These data
suggest that hyperparathyroidism could be a pathogenetic cofactor
in gastric hypersecretion of uremic patients.
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Therapeutic trials of anemia in renal failure. S. Band/ni, L. Corn-
par/ni, F. Martine/li, M. Salvadori, P. Tosi, and A. Sodi. Dialysis
Department. S. Maria Nuova Hospital, Florence. Anemia in the
course of chronic renal failure has a multiple pathogenesis. For the
purpose of finding an optimal therapeutic scheme we intend to
propose various diagnostic approaches to this problem, thus iden-
tifying the main pathogenetic states involved in every single case of
anemia in the course of chronic renal failure. We describe the
results of a year's work on this problem in our department and
illustrate some therapeutic schemes to utilize in the treatment of
chronic renal failure patients in order to improve their hematologic
values. We are trying to emphasize, in particular, the good results
we obtained using cobalt acetate on a significant number of
patients on a chronic hemodialysis program in our center. Our
experiences about the use and effects of cobalt therapy in anephric
subjects lead us to conclude, in accordance with the most recent
data found in literature, that there must be some extrarenal sources
of REF.
Evidences for the pathogenic action of the IgE-dependent baso-
phil's degranulation mechanism in human glomerulonephritis. J. Ben-
yen/ste. G. Carnussi, G. Piccoli, A. Vercellone. Clinique Nèphrolo-
gique, Hbpital NECKER, Paris; Cattedra di Nefrologia Med/ca
dell'Università di Torino. Divisioni di Nefrologia e Dial/si, Ospedale
Maggiore di San Giovanni Battista e della Città di Torino. In
experimental models of glomerulonephritis (acute serum sickness),
the localization of circulating immune complexes within glomeruli
results from cooperation of hydrodynamic factors and increased
vascular permeability because of the release of vasoactive amines
with a basophils-IgE-dependent immune mechanism. In human
glomerulonephritis, while evidence has been brought for the action
of hydrodynamic forces, little is known about the basophils-me-
diating immune system of vasopermeation. We analyzed the be-
havior of basophils and correlated it with the different stages of
evolution of the nephropathy. In particular, the results obtained in
two cases of acute glomerulonephritis with pronounced exudative
changes are reported in relation to basophils' poo1 changes and
degranulation investigated with a method of meachromatic color-
ing. The presence of a fairly high number of degranulated baso-
phils with "cups" of IgE within glomeruli was also noticed. On the
basis of clinical evidence and experimental data, the hypothesis is
formulated of an active IgE-dependent basophil degranulation
with release of histamine and PAF (Platelet-Aggregating-Factor),
a soluble factor which induces platelet aggregation and their Se-
rotonin release. The action of vasopermeation in the deposition of
circulating immune complexes is moreover discussed.
Fibrinogen metabolism in chronic uremic patients undergoing peri-
odic hemodialysis (in vivo and in vitro study using J125 fibrinogen. M.
Bertoli, E. Bertaglia, D. di Landro, L. Gasparotto, N. Penn and G.
F. Rornagnoli. Servizio di E,nodialisi dell'Ospedale Civile di Padova,
('linica Med/ca I deIl-Univer.sità di Padova. Fibrinogen metabolism
has been studied in 12 chronic uremic patients undergoing periodic
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hemodialysis by evaluating at the beginning and at the end of each
dialysis treatment: Quick's test, coagulation-time test, thrombo-
elastogram, fibrinogen plasma concentration, platelet count,
plasmatic fibrinogen degradation products (FDP), and fibrinogen
half-life during dialysis and interdialytic phase. Fibrinogen concentra-
tion in plasma and platelet count did not present any significant
variation between the predialytic and the postdialytic phase. Fi-
brinogen half-life was significantly reduced during dialysis, but was
normal in the interdialytic phase. Plasmatic FDP were increased
during the postdialytic phase. Further experiments were carried
out on fresh human blood samples treated with an antiproteolytic
(Trasylol). The treatment resulted in: increased fibrinogen half-life,
plastmatic FDP reduction, and increased membrane-bound radio-
activity.
Erythropoiesis in chronic uremia: Effects of early dialysis and
transplantation. V. Bonomini, A. Albertazzi. Department of Nephrol-
ogy and Dialysis, Chair of Nephrology, St. Orsola University Hospital,
Bologna. The erythropoietic changes were evaluated in a semi-
quantitative study in an attempt to achieve a better definition of
the term "rehabilitation" in chronic uremic patients undergoing a
substitutive program. Patients on dialysis showed that in the same
residual renal function the depression in erythropoiesis is progres-
sively more marked in patients with vascular nephrosclerosis and
glomerulonephritis than in patients wiht pyelonephritis and poly-
cystic kidney disease. The yearly need of blood transfusion was
respectively 8, 5,4, and 0 units. With earlier dialysis (residual renal
function above 10%), the severe depression in erythropoiesis may
be prevented and better controlled. It is likely that this fact might
play a determining role in the different patterns of erythropoiesis in
"early" with respect to "late" dialysis, with consequent different
clinical pictures and need of blood transfusions. The resumption of
erythropoietic activity after transplantation has been found con-
stantly with normalization of all parameters after 2 to 4 months. In
successful transplantation, the normalization of erythropoiesis per-
sists for several years, and sometimes may be excessive, yielding to
clinical and laboratory findings of secondary polycythemia, likely
secondar.y to stimulation of erythropoietin and prolonged predni-
sone treatment. In living donor transplantation, the resumption of
erythropoietic activity is sometimes more spectacular and earlier in
respect to cadaver donor transplantation.
Effects of bicarbonate treatment on cellular potassium "capacity"
in chronic renal failure (CRF): Investigations performed by muscle
needle biopsy and external balance. A. Borghetti. A. Montanan, L.
Borghi, M. Canali, A. Guariglia, and A. Novarini. Instituto di Se-
nieiotico Medico dell' Università di Parma, Parma, Italy. Serum
potassium is the resultant of both extracellular pH and the ratio
between body potassium content and cellular potassium "capac-
ity," i.e., the amount of cellular potassium-binding molecular
groups. In CRF patients with acidosis, when more bicarbonate
than calculated to correct extracellular bicarbonate defect is given
with potassium, we can obtain a potassium retention greater than
expected on the basis of relations among extracellular pH, serum
potassium and content-"capacity" ratio. This can be explained
with intracellular titration of hydrogen ions chronically bound
with buffering groups, probably identical with those that bind
potassium. Potassium "capacity" is therefore reduced in chronic
acidosis and this could be reversible when the administration of
bicarbonate is able to increase significantly the bicarbonate cellular
content. In a group of uremic subjects with acidosis and potassium
depletion, on a correct protein and caloric balance, we have eval-
uated, before and after potassium and bicarbonate administation:
I) the potassium and nitrogen content of skeletal muscle (needle
biopsy); 2) the external balance of potassium and bicarbonate. In
all subjects, the potassium repletion is significantly greater than
that predictable by extracellular parameters; the increase of muscle
potassium and positivity of external balance of potassium are
correlated with external balance of bicarbonate.
On the mechanism of the antihypertensive effect of furosemide. A.
Borghetti, G. Bruschi, A. Mutti, A. Biggi, and A. Novarini. Istituto di
Se,neiotico Medico dell'Università di Parma. Diuretics can be con-
sidered antihypertensive agents because they reduce the blood
pressure of patients with essential hypertension and yet have no
effect on the blood pressure of normal people. The mechanism of
their antihypcrtensive action is not well established. To evaluate to
what extent the antihypertensive effect of furosemide depends
solely on maintenance of salt water depletion, we have measured,
in 8 subjects with essential hypertension, the plasma volume, ex-
changeable sodium and potassium, arterial pressure, cardiac out-
put, and calculated the peripheral resistance. This was followed by
the administration of furosemide, 1 mg/kg of body wt per day for 5
days. After discontinuing the diuretic, body salt and water were
restored to initial conditions by means of saline infusions for 5
days; hemodynamic indexes were again measured; Na and K ex-
ternal balances were calculated. At the end of the infusion period,
the plasma volume was slightly increased (+4.5%). In spite of this,
arterial pressure was decreased (—14%), and this was concomitant
with a fall both in cardiac output (—5%), and peripheral resistance
(—9%). These data suggest that furosemide, besides lowering blood
volume, produces a hemodynamic rearrangement that leads to a
decrase in cardiac output and peripheral resistance.
Biochemical and histological effects of dihydroxycholecalciferol
(1,25-OH-D3) in severe uremic osteodystrophy therapy. G. C'. Borto-
lotti. ( Feletti, L. Pitton, V. Bachi, V. Bonomini. Servizio di
Nejrologia e Dialisi, Ospedale Policlinico S. Orsola, Bologna; Clin-
ica C'hirurgica B, Sezione E'nodialisi, Ospedale Policlinico. Genova.
Italy. I ,25-OH-D3 was given in a dose of 25 ,zg/day for a mean of
three months to five patients on regular dialysis with severe uremic
osteodystrophy. During the treatment a significant improvement in
the clinical picture of all the treated patients was observed from the
second month onward. Radiologically, the hyper-resorbtion signs
were significantly improved in three patients, while they remained
unaltered in the other two, with no change in preexisting vascular
calcifications. Biochemically, a slow but progressive decrease in the
PTH serum levels (3.8 + 1.2 ng/ml, initial values; 1.8 0.4 ng/ml,
final values) was noted; the same in the alkaline phosphatase (90 +
30 U, pretreatment; 60 + 10 U, posttreatment). Serum Ca and P
were not significantly modified. Before treatment, bone histology
showed severe hyperparathyroidism signs (Howship lacunac sur-
face: 13.8 + 4.9%; osteoclast index, 24.2 ÷ 9) and hyperosteoidosis
(osteoid surface, 60.2 + 14.4; osteoid volume, 9.4 2.2%). After
treatment, a rapid and intense decrease in the hyperparathyroidism
signs was verified (Howship lacunae surface, 7.4 + 2.1%; osteoclast
index, 8.1 + 4.4). However, the hyperosteoidosis degree was only
slightly decreased (osteoid surface, 42.3 + 10.4%; osteoid volume,
7.0 +4.5).
Treatment of uremic osteodystrophy with 25-OH cholecalciferol.
D. Brancaccio, G. Mioni, G. Graziani, C. Galmozzi, and G. Banfi.
Divisione di Nefrologia e Dialisi, Padiglione Croff Policlinico di
Milano. Divisione di Nefrologia e Dialisi degli O.spedali Civili di
Brescia. The inefficacy of high and prolonged doses of ergo and
cholecalciferol in some uremic patients and the observation of low
serum calcium levels in hemodialyzed patients given anticonvul-
sants suggest the therapeutic use of 25-OH cholecalciferol (25-OH
CC) in the treatment of renal osteodystrophy. All four patients
undergoing treatment with 25-OH CC (2 anephric and 2 with their
own kidneys) were in regular dialysis treatment (RDT) for at least
4 years and showed clinical, biological, and radiological signs of
osteodystrophy. The therapeutic schedule consisted of progres-
sively increasing oral doses (100 gig, 200 sg, 400 sg/day) over a
period of observation ranging from 20 to 80 days. Calcium in-
testinal absorption (by single oral dose of stronium chloride), free OH-
proline serum levels, alkaline phosphatase, plasma calcium, and
plasma phosphate were checked at the beginning and end of every
therapeutic step. Even though significant variations of calcium
plasma levels were not evidenced, even with dosages as high as 400
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isg/day, intestinal absorption capacity of calcium considerably
improved in anephric patients (10% to 50% and 8.3 to 15.7% of
total SrCI absorbed, with 400 /ig/day of 25-OH CC), as well as in
uremic patients with their own kidneys (10% to 17% and 50% to
54%, with 100 ,.sg/day of 25-OH CC). Moreover, our results in
anephric patients may prove that OH hydroxylation of Vit. D in 1
position is not essential for intestinal absorption of calcium. On the
contrary, in those patients undergoing spontaneous or pharma-
cologic hepatic enzymatic induction, the use of 25-OH CC proved
essential.
Hypophysial and Leydig cell functionality in chronic uremic males.
M. Bruno, G. Vacha, G. Giorcelli, P. Bajardi, M. Marangella, B.
Fruttero. F. Linari. Div. Nefrologia e Dia/isi; Primario: Prof F.
Linari, Ospedale Mauriziano ' Uniberto I" di Torino. G. Cendarelli,
A. Ba/samo, U. De Filippis. Div. Ma/a/tie Endocrine e Metabolichi;
Pr/mario: Prof U. De Fi/ippis, Ospedale Mauriziano ' Umberto I,"
di Torino. Follicle-stimulating hormone (FSH), luteinizing hor-
mone (LI-I), and testosterone values were determined in 38 subjects:
IS normal controls, 10 chronic uremia patients not under dialysis,
and 13 receiving periodic hemodialysis. Stimulation with GnRH
and HCG was also performed in 8 uremic subjects (5 in dialysis
and 3 not). Testosterone and LH were significantly lower and
higher, respectively, in the two uremic groups than in the controls,
whereas FSH was significantly higher in subjects under dialysis
than in the other two groups. The dynamic tests showed both
testicular and hypophysial deficiency, pointing to damage to both
of these organs in uremia.
Ultrastructural observations on the glomerular epithelium in min-
imal change nephrosis. L. Cagnoli, S. Casanova, M. Sasdelli, U.
Donini, and P. Zucchelli. Department of Nephro/ogy and Dialysis,
Malpighi Hospital, Bologna, italy. Experimental studies on rats
made nephrotic by puromycin suggest that glomerular epithelial
cell changes (including swelling, vacuolization, and detachment
from the basement membrane) play a pathogenetic role in protein
leakage through the glomerular filter. Alternatively, these changes
may simply reflect the epithelial cell reaction to proteinuria. Ultra-
structural observations on renal biopsies from patients with min-
imal change disease, the possible human counterpart of amino-
nucleoside nephrosis, were performed in order to assess the presence
of similar epithelial cell alterations in man. Biopsies from another
proteinuric disorder with well defined pathogenesis, membranous
glomerulonephritis, were then studied to ascertain the specificity of
these changes. We have found epithelial cell detachment, in some
cases with severe proteinuria, occurring in patients with minimal
change disease as well with membranous glomerulonephritis. Nev-
ertheless, renal biopsies from some patients with severe nephrotic
syndrome, in both groups, did not show this kind of lesion. The
following conclusions may be drawn: I) epithelial cell changes
might occur in various glomerular diseases characterized by dis-
tinct pathogenetic mechanism; 2) this lesion may represent a late
consequence of proteinuria rather than a primary event.
Lecithin-cholesterol acyltransferase activity in chronic uremic
patients. L. Campanacci, G. F. Guarnieri, M. Moracchiello, F.
(Irs/ni, L. Fern, M, Valente, and C. Grego/in. In,stituto di Pat ologia
Medica, Universitb di Tries/c and is//two di Chi!nica Biologica,
Università di Padova. High incidence of hypertriglyceridemia in
chronic uremic patients has been reported, with lipoprotein pattern
abnormalities, mainly resembling type IV and Ill hyperlipoprotei-
nemia. On the other hand, a decrease of plasma HDL has been
described in the absence of renal function. Decreased triglyceride
turnover and plasma lipoprotein lipase activity (LPL) have also
been reported in chronic uremic patients. In these patients, other
investigators have found a decrease in phospholipids, cholesterol
esters, lysolecithin, and polyunsaturated fatty acids. An impaired
rate of VLDL catabolism and abnormal LDL are also present in
chronic uremia. A most important contribution to these abnor-
malities might be an impaired activity of the enzyme lecithin-cho-
lesterol acyltransferase (LCAT), which uses fatty acids in the 2-
position of lecithin for cholesterol esterification.
Proposal for a new method to evaluate the vasoconstrictive, refill-
dependent component in hypertensive patients with impaired renal
function. C. Campieri, L. C. Borgnino, G. Mangiafico, and S. Mart i-
ne/li. Nephrologv and Dialysis Department, St. Orsola University
Hospital, Bologna, Italy. Forty untreated hypertensive patients of
various etiologies and with serum creatinine values ranging from
0.6 to 17 mg/l00 ml were included in the study. The level of
hypertension was expressed in four degrees, according to the dias-
tolic blood pressure (Gr. 1, 90 to 100 mm Hg; Gr. 2. 100 to 110;
Gr. 3, 110 to 120; Gr. 4, greater than 120). Two plasma renin
activity (PRA) determinations were done in every patient: one in
the supine position (A): then 50 mg of Lasix was given by mouth,
and after five hours of upright posture a second determination was
carried out (B). From these two values, an index of PRA increment
was determined (RI = renin index = B A/A). Five patients with
Gr. 3 renovascular hypertension presented values of RI between
0.13 and 0.44 with a mean of 0.3. Twelve patients with essential
hypertension presented RI values proportional to the degree of
hypertension with the exception of the low-renin group (Gr.3 =
1.8, Gr.2 = 5, Gr.I = > 7, LR group = 1.12). Fourteen patients
with chronic glomerulonephritis presented a constant product (RI
X creatinine) for each hypertensive grade (Gr. I = 2.8, Gr.2 = 5.4,Gr.3 = II). Four patients with nephrosclerosis presented an aver-
age of 0.43. We concluded that RI has a low value in those cases in
which the renin-dependent vasoconstriction is most active; the only
exceptions are the low renin groups which are easily identifiable.
This test is especially valuable in the patients with impaired renal
function.
Reutilization of dialysis membranes and coagulation. C. Canavese.
P. S/rat/a. G. Mangiarotli, A. Pad/ti, G. Segoloni, A. Verve/lone.
Cat/edna di NeJrologia Medica dell'Univer,citb di Torino, Divisione
di Nefrologia e Dial/si, Ospedale Maggiore di S. Giovanni Battista e
della Cit/a di Torino. Coagulation was investigated in patients
undergoing dialysis with the technique of reused membranes. The
study was performed in 12 patients: five were dialyzed with Gam-
bro Lundia Major, five with Gambro Lundia 13.5, and two with the
Dow Cordis IS. Membranes were utilized for a minimum of three
to a maximum of six times. For every use the following parameters
were adopted: fibrinogen, the products of fibrinogen degradation,
platelets, reptilasis time, thrombine time, platelet aggregation, sys-
temic fibrinolysis, hematocrit and erythrocyte morphology. Be-
sides the preceding ones, optic microscopic studies and immu-
nofluorescence preparations were performed on the membrane of
the dialyzers. With the first use of the dialyzers the following
results were obtained: I) reduction of platelet number in 15 mm; 2)
constant fibrinogenemia; 3) stimulation of the platelet aggiegation
only in the presence of substrate already hyperaggregated; 4) 6-
brinolytic system potential increase at the end of dialysis. All of these
modifications were more evident in those cases which show a
tendency to thrombosis. During the successive usages of the dialy-
zers, there were no sensible hemostatic variations from the first
usage. In patients who show tendency to thrombose, slight varia-
tions were noticed in successive dialyses.
Dialysis and transplantation. A. Cantaluppi, A. Fran/mi, R. Licini,
and G. Mecca. Divi.cione di NeJro/ogia e Dialisi, Ospedali Riuniti di
Bergamo. At the "Ospedali Riuniti di Bergamo" since 1972, be-
cause of the continuing cooperation from the Depart'ients of
Anaesthesia and Neurosurgery, it has been possible to procure a
satisfactory number of cadaver kidney donors: thi/ allowed us to
carry out an integrated program of dialysis and renal trans-
plantation. One hundred and eight patients, treated by hospital
and home dialysis, were listed for transplantation; fifty-seven
could be transplanted (55 with cadaver grafts). This permitted us
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to compare the results of a policy of dialysis 'per se (51 patients,
age 38 9 years; dialysis age, 35 + 24 months) with the results of a
policy of dialysis integrated with transplantation (57 patients, age
35 8; age of treatment, 41 23 months). The integrated program
has achieved an actuarial survival rate of 97% at one year and 85%
at six years. Graft survival was 60% at four years. The dialysis per
se has achieved an actuarial survival rate of 98% at one year and
88% at six years. 89% of transplanted patients are fully rehabilitated
as compared to 67% of dialysis patients (x2 4.54, P < 0.05).
These results demonstrate that an integrated program of dialysis and
transplantation offers a chance of life not different than that of
dialysis alone, and a better rehabilitation. Moreover, the maximum
number of patients will be treated with the fullest use of available
dialytic resources.
Surface properties and functional characteristics of cells infil-
trating renal allografts. A. Canlaluppi, G. Banfi. A. Tarantino, and
C. Ponticelli. Sezione di Nefrologia e Dialisi, Ospedale Policlinico,
Milano. To determine the identity and functional capacity of lym-
phoid cells involved in allograft rejection, we studied viable mono-
dispersed cells recovered from 15 rejected human renal allografts
by Ficoll-Isopaque gradient separation. The surface properties of
these cells have been characterized and correlated with the histo-
logic patterns of rejection. The infiltrating cells consisted of macro-
phages (16 to 28%), polymorphonuclearleukocytes (approximately
5%), and lymphocytes (60 to 80%). B lymphocytes, bearing surface
Ig and T lymphocytes (E-rosetting cells) comprised 19 to 51% and
31 to 71% of all infiltrating cells, respectively. Cells bearing Fc
receptors, identified by membrane binding of heat aggregated 'y-
globulin, were abundant (16 to 55%), whereas complement recep-
tor lymphocytes (EAC-rosetting cells) were uncommon (Ito 6%).
'l'he surface attributes of the infiltrating cells were compared to
those of simultaneously sampled cells from recipient peripheral
blood. In order to evaluate the functional capacity of lymphoid
cells, a modified Rosette Inhibition Test was also performed: 14
infiltrates contained cells with a minimal inhibitory concentration
of antilymphocyte globulin greater than that of corresponding
blood lymphocytes. These data indicate that a heterogeneous pop-
ulation of mononuclear cells are present in rejected human renal
allografts; moreover, the concomitant study of peripheral blood
leukocytes and infiltrating cells demonstrates that the last represent
a population distinct from the circulating pool of mononuclear cells
and not simply a random accumulate from blood within the graft.
Finally, since as many as 55% of the cells recovered from the renal
allografts bore Fe receptors, a role for antibody-dependent target-
cell lysis in the rejection process is suggested.
Plasma renin activity (PRA) and urinary sodium excretion after
furosemide injection in patients with glomerulonephritis at different
GRF values and blood pressure. G. Capelli, G. Di Maio, and S.
Lamperi. Division o/ Nephrology and Dialysis, Genoa Hospital,
Genoa, liaR'. Hypertension is a common feature of chronic glome-
rulonephritis. Several factors may be involved in the pathogenesis:
volemia, extracellular fluid volume, total exchangeable sodium,
plasma renin activity. Recent studies have suggested that subtle
abnormalities relative to body sodium and to PRA may occur after
the earliest stages of glomerulonephritis and may contribute to
make such patients hypertensive. These abnormalities could in-
dicate a subtle reduction of urinary sodium excretion in the very
early stages of renal disease, This study was undertaken to evaluate
the mechanism of urinary sodium excretion of the patients with
chronic glomerulonephritis. Thus VFG, CNU, TN,, C0,,, PRA
were evaluated after furosemide injection in 30 patients with
glomerulonephritis at various stages and various levels of blood
pressure. The following observations were made: I) in patients
with normal blood pressure sodium excretion was low, while hy-
pertensive patients have normal urinary sodium excretion; 2) after
furosemide injection, urinary sodium excretion was significantly
higher in hypertensive patients than in normotensive patients; 3)
these results were more clearcut in patients with end-stage glome-
rulonephritis than in those with early stage glomerulonephritis; 4)
PRA was higher in hypertensive patients after furosemide.
Serum and urinary fibrin/fibrinogen degradation products (FDP)
in renal disease. S. Carozzi, R. Vagge, G. Molinelli, and S. Lamperi.
Division of Nephrology and Dialysis. Genoa Hospital, Genoa, Italy.
Creatinine clearance, serum and urinary fibrin/fibrinogen degrada-
tion products (FDP), serum fibrinogen blood, platelets, and pro-
tein excretion were evaluated in 37 patients with glomerulo-
nephritis with high or low protein excretion (9 of these patients
have been studied before and after treatment with indomethacin,
cyclophosphamide, heparin alone or in combination with dipyrida-
mole) in II patients with chronic renal insufficiency on con-
servative therapy or on hemodialysis or transplanted, in 9 patients
with acute renal insufficiency, in 15 patients with preeclampsia (7
patients have been studied before and after treatment with heparin
alone or in combination with dipyridamole). The following obser-
vations were made: I) there is no correlation between the values of
serum and urinary FDP in the patients studied; 2) there is good
correlation between the values of FDP excretion, creatinine clear-
ance, and proteinuria in patients with glomerulonephritis, and a
significantly higher protein excretion before and after treatment
with indomethacin; 3) in patients with glomerulonephritis. FDP
excretion decreased during treatment with heparin or dipyridamole
while proteinuria remained unchanged; 4) no correlation exists
between FDP excretion and proteinuria in preeclampsia and in
transplanted patients before and after treatment with heparin
alone or in combination with dipyridamole.
Beneficial and detrimental effects of hemodialysis on uremic
anemia. A. Castellani, L. Cristinelli, M. Mi/eli, F. Brandi, S.
Mombelloni, G. Mioni. G. Gregorini, R. Maiorca, P. U. Guerra. G.
Maira, I.. Spandrio. Division of Nephrology. Service of Nuclear
Medicine, A na/isis Laboratory, Civil Hospital, Brescia. Hemo-
dialysis may act by two ways on uremic anemia. The negative
effects are prevalently the depletive and hyperhemolytic ones. The
causes are recognizable and, at least partially, eliminable. So, it is
possible to avoid the hemolytic factors linked to an incorrect
dialysis-water preparation and to an incongruous administration
of oxidizing drugs, and it is also possible to get a normal red
corpuscle half-time in about 65 to 70% of the patients in spite of the
high levels of urea and creatinine. The hypersplenism seems to be a
secondary event, and it is present, in these conditions of dialysis, in
less than 10% of the patients. The depletive factors may also be
reduced by a diet particularly rich in proteins, wherefore it seems
to be barely important a suppletive requirement of folic acid. If
these measures are followed, hemodialysis shows its positive effects
on the red corpuscles, effects that progressively appear (dialytic age
vs. hematocrit, direct correlation P < 0.05). The above mentioned
measures permit us to obtain, among a non-preselected dialytic
population (with exclusion of anephric and polycystic patients),
without transfusions, androgenic therapy, or splenectomy, a pre-
dialytic hematocrit of 28.9 5.8 in the males and 24.7 5.2 in
the females. The mechanism by which hemodialysis increases the
production of red corpuscles is debated: anyway, neither the degree
of "depuration," nor an early dialytic treatment seem to be pre-
eminent factors. It seems possible, in fact, that uremic anemia may
be an accommodation phenomenon and that the dialysis treatment
acts on the factors which, by making easy the oxygen dismission by
the red cells, decrease the already depressed synthesis of the eryth-
ropoietin. The production of red corpuscles may be ulteriorly
stimulated by a pharmacologic or dialytic way, which gives an
hypoxic stimulus (cobalt, intensive dialysis, and the androgens).
Within certain limits such an action may be useful. In fact, there
are some "uremic" situations in which a positive effect is exerted
by the red corpuscle mass rather than by their capacity to leave
oxygen.
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Nephrotoxic serum nephritis in rat: Scanning electron microscopy
of podocyte. A. Cioffi, F. Conte, M. Del Poll, M. Colombi, G.
Barbiano di Belgioioso, A. Sessa. Sezione di Nefrologia e Dialisi,
Ospedale Civile di Vimercate, Divisione di Nefroiogia e Dialisi,
Ospedale Maggiora di Milano, Centro di Cit ofarmacologia del CNR,
Istituto di Farmacologia dell'Universitb di Milano. After induction
of nephrotoxic serum nephritis in rats, we have performed a scan-
ning electron microscopy study that has pointed out podocytic
surface changes directly related with the amount of proteinuria.
The alterations consist of disorganization of podocytic branching,
disappearance of pedicles, and appearance of drop-like protrusions
(only in rats sacrificed on the 21st day). Such changes recall those
seen in other proteinuric glomerulopathies. Of doubtful meaning
are the appearance of the drop-like protrusions which are neither
correlated to proteinuria level nor to a GFR reduction.
Glomerular receptors for C3b. G. Colasanti, J. Mora,4, and D. K.
Peters. Divisione di Nefrologia e Dialisi, Ospedale S. Carlo Bor-
romeo. Milano, and Department of Medicine, Royal Postgraduate
Medical School, London. The normal human glomerulus contains a
receptor specific for the activated third component of complement,
C3b. The receptor is detected using fluoresceinated S. typhi con-
jugated with C3b and then incubated with frozen sections of kid-
ney. We report the results of examining the receptors in 150 renal
biopsies. Marked reduction in number, or absence of the receptors,
was observed in acute glomerulonephritis (12 cases), mesangio-
capillary glomerulonephritis (20 cases), membranous glomerulone-
phritis (II cases), and rapidly progressive glomerulonephritis (16
cases, 8 with antiGBM antibodies). Receptors were normal, or
nearly so, in IgA mesangial nephropathy (15 cases), Henoch-
Schonlein purpura (3 cases), "minimal change" glomerulonephritis(6 cases), and acute tubular necrosis (6 cases). In 6 cases of
focal glomerulosclerosis, reduction of receptors was seen only on
damaged glomeruli. Reappearance of receptors was seen in serial
biopsies from 2 patients (I case of mesangio-capillary glomerulo--
nephritis and I case of Goodpasture's syndrome), both associated
with substantial improvement of renal function. In SLE nephritis,
the receptors were normal in 4 cases with focal disease, and re-
duced in 2 with diffuse disease. These results suggest involvement
of C3b receptors in diseases associated with damage to capillary
loops.
Immunofluorescence study in postinfective glomerulonephritis. G.
Colasanti. G. Barbiano di Belgioioso, A. Tarantino, L. Guerra, A.
Durante, and A. Ragni. Divisioni di Nefrologia e Dialisi: Ospedale
Maggiore S. Carlo Borromeo, Milano, Ospedale Maggiore "Ca
Granda," Milano, Ospedale Maggiore Policlinico, Milano. Sixty-
two patients with acute postinfective glomerulonephritis (AGN)
were divided into two groups according to the immunofluorescent
findings on renal biopsy: C3 alone (32 patients), or C3 + lgG (30
patients). The clinical data, histological findings, and further
course (follow-up: six months to four years) of the two groups have
been compared. The two groups were identical with regard to the
time of renal biopsy after onset of the disease. At 12 months, 50%
of the patients with C3 + IgG showed evidence of continuing
disease (proteinuria in 8, microscopic hematuria in 11, renal
impairment in 6) vs. only 16% for the isolated C3 group (protein-
uria in four cases, microscopic hematuria in four cases, renal
impairment in three cases). This difference persisted at 24 months
when 30% of the C3 + lgG patients showed evidence of continuing
disease activity (proteinuria in five cases, microscopic hematuria in
six cases, renal impairment in three cases) vs. 10% for the isolated
C3 group (proteinuria in one case, microscopic hematuria in two
cases). These results indicate that the finding of IgG deposits in
patients with AGN may be associated with a less favorable prog-
nosis.
Effect of acute ureteral obstruction (UO) on dynamics of ultrafil-
tration (DU) in rat kidney. A. Dal Canton, R. Stanziale, A. Corradi,
GE Maruccio, and L. Migone. II Clinica Medica, University of
Parma, Parma, Italy. It has been demonstrated that glomerular
filtration is maintained early after UO despite a marked rise in
intratubular pressure (ITP). No measurement of single nephron
glomerular filtration rate (SNGFR) has been reported as yet dur-
ing complete UO. This study was undertaken to evaluate DU in rat
kidney one hour after ureteral ligation. Glomerular capillary pres-
sure (GCP) and pressure in first order peritubular capillaries
(EAP) and TTP were directly measured with a servo nulling system.
SNGFR was measured by micropuncture in control conditions
and calculated from efferent arteriole blood flow (EABF) and
single nephron filtration fraction (SNFF) during UO. Afferent
arteriole blood flow (AABF), resistance of afferent (Ra) and effer-
ent (Re) arterioles were also calculated. UO markedly increased
ITP (+ 180%). The fall in SNGFR (—24%) was blunted by the rise
of GCP (+29%) and AABF (+20%), accounted for by a decrease
in Ra (—33%). EABF increased (+28%). Re was lowered (—15%)
by the reduction of hematocrit of efferent blood, accounted for by
a decrease in SNFF. These results demonstrate that SNGFR is
maintained early after complete UO and that afferent arteriole
dilatation accounts for the phenomenon.
Free amino acid concentration in plasma and erythrocytes in
uremia. P. Dall'Aglio, C. Buzio, G. Delmonte. II Clinica Medica,
Università di Parma, Italy. In normal subjects some free amino
acids show an intraerythrocytic concentration equal to that of the
plasma; some others, on the contrary, show a concentration in the
erythrocytes significantly increased or decreased in comparison to
that of the plasma. This involves the existence of still unknown
active gradients of concentration at the erythrocyte membrane
level. In this study we have evaluated the extra- and intra-
erythrocyte concentration and the extra/intra ratio of the free
amino acids in 11 chronic uremic patients (creatinine, 9 mg/l00
ml) with normochromic anemia treated only with a controlled
protein intake in comparison with seven healthy subjects. The most
significant differences have been found in amino acids such as
leucine, phenylalanine, taurine, and proline, whose extra/intra
ratio had significantly decreased in uremics because of the in-
creased intracellular concentration. Also the extra/intra ratio of
the serine, valine, isoleucine, tyrosine, and lysine had decreased as
a consequence of the diminished extracellular concentration. These
results suggest that the peculiar behavior of the erythrocyte mem-
brane in uremia, very different from that of the other forms of
anemia, is above all a consequence of pathological metabolism of
the uremia syndrome.
Long-term effects of regular dialysis treatment on plasma protein
concentration: Results over the past nine years. P. Dall'Aglio, L.
Scarpioni, V. Cambi, C. Buzio, L. Ansi, P. G. Poisetti, G. Bordi,
L. Migone. II Clinica Medica, Università di Parma, Italy, and II
Divisione Medica, Ospedale Civile di Piacenza. Italy. In patients
submitted to regular dialysis treatment for different periods of time
(from a few months to 9 yr), the concentration of total protein and
different proteins (prealbumin, albumin, alfa I AcGP, alfa I ATr,
alfa 2 M, RBP, beta I C, transferrin, beta 2 GPI, hemopexin, hapto-
globulin, IgA, IgG, 1gM, and lysozime) has been repeatedly evalu-
ated. From 1966 to 1967 the dialytic strategy has changed in our
center. Up to 1970, all patients underwent standard Kiil dialysis (10
hr/3 times/week); afterwards all patients after a short experience
with low flow dialysis were treated with short-time KoIff-Coil dialysis
(4 hr/3 times/week). The short-time dialysis reduces the small
molecule loss as shown by the increased creatinine levels. A similar
reduced loss of amino acids is likely. In all patients an increase to
normal values of the concentration of total protein and of most
protein fractions, such as albumin, were shown. This normaliza-
tion remained during the following years. Some proteins, on the
contrary, showed a different behavior. Transferrin levels were al-
ways lower than normal controls, while the concentration of
smaller proteins and microglobulins, normally increased before
dialysis, remained high. These results show that the nutritional
status and protein metabolism are not completely corrected by the
different, dialytic treatments utilized up to now.
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Iron therapy andiron kinetics. P. D'Amico, F. Filoramo, Maria
Grazia Grassi Prina, C. Dadone, and B. Redaelli. Nuclear Medicine
Department, General Hospital, Monza, Italy, and Nephrology and
Dialysis Service, General Hospital, Monza, Italy. In 33 chronic
uremic patients receiving thrice-weekly hemodialysis, iron kinetics
were investigated, external counts were made and serial blood
samples were taken. On the basis of the radioactivity measured
from outside, patients were divided into three groups: a) those with
a normal bone marrow and liver curve; b) those with impaired
bone marrow uptake but normal liver tracer uptake; c) those with
reduced bone marrow activity and clearly increased intrahepatic
accumulation of radioiron. Nine blood test values and ten clinical
parameters were calculated for the patients in each group. Statis-
tically, significant correlations were found between almost all the
clinical parameters and the three categories of patients. With a
view to prescribing iron therapy for all the patients considered, the
results of iron kinetic study were used to check whether changes in
Ht, Hb, and plasma iron before and after administration of iron
correlated with normal or abnormal plasma iron clearance. The
patients with plasma iron clearance > 1.6 hr showed no improve-
ment in Ht, Hb, and sideremia, whereas patients with clearance <
1.6 hr gave a significant increase in all three values. To conclude,
an iron kinetic study using external counts provides a means of
distinguishing patients from the clinical point of view, while assess-
ment of plasma iron clearance identifies patients likely to gain from
iron therapy.
Alternative metabolic pathways for renal ammonia production in
chronic renal insufficiency (CR!). G. De Ferrari, A. Tizianello, G.
Gurreri, G. Garibotto, and L. Barberis. Department of Internal Medi-
cine, Chair of Medical Nephrology, and Department of Surgery I.
Chair of Cardiosurgery, University of Genoa, Italy. The mammalian
kidney is provided with several enzymes capable of producing
ammonia from different amino acids. Glutaminases which catalyze
the deamidation of glutamine are the most important enzymes for
ammonia production in vivo. However, our previous observations
on renal inability to utilize glutamine for ammonia production in
chronic renal insufficiency suggested that in this condition the
major role in ammoniagenesis is played by enzymes and substrates
other than glutaminases and glutamine. In this study we measured
renal extraction of amino acids and total ammonia production in
five patients with CR! and a GFR between 30 and 10 mI/mm.
Ammonia production was 24 + 3.7 imole/min (50 + 1.8
mole/min in normal controls), glutamine extraction was negli-
gible, whereas a significant renal uptake of proline, alanine, and
glycine was observed. The extraction of these amino acids was
adequate to account for the total ammonia production. These data
demonstrate the existence of alternative metabolic pathways for
ammonia production operating in chronic renal insufficiency. The
effectiveness of such pathways is shown by the high rates of am-
monia production per unit of GFR in CR1 (1.0 mole/min/ml
GFR) as compared to normal subjects (0.4 pmole/min/ml GRF).
Inhibition of spontaneous rosette formation test by pre- and post-
dialysis uremic sera. C. De Simone, M, Taccone Gallucci, A. Ci-
cogna, Casciani. Istituto di Malattie Infettive e Tropicali, University
of Rome, Italy, and Istituto di Semeiotica Chirurgica III, University
of Rome, Italy. Experiments were undertaken to try to detect in
serum obtained from uremic patients on intermittent hemodialysis
a blocking factor leading to suppression of the spontaneous rosette
formation with lymphocytes of normal random donors. In two
uremic patients, the sera obtained before and after hemodialysis
were tested together with a reference serum which was a pooi from
normal AB blood donors. We applied the analysis of variance
for a two-level factor and an opportunely modified correlation
coefficient. P < 0.01 was accepted. Our stud indicates that uremic
sera obtained before hemodialysis show a constant blocking activ-
ity which is still present after dialysis. Furthermore, it will show
that this inhibition occurs only in some subpopulations of T lym-
phocytes.
Anemia of chronic renal disease: 1. Pathogenesis. A. J. Erslev.
Department of Internal Medicine, Thomas Jefferson University,
Philadelphia, Pennsylvania. The anemia of chronic renal disease is
caused by a complex interaction between increased red cell loss and
decreased red cell production. The increased loss and destruction
appear to be proportional to the degree of azothemia and may be
ameliorated by dialysis. The decreased production, on the other
hand, is related to a loss of normal renal parenchyma and can not
be easily compensated for. The normal renal parenchyma monitors
oxygen tension or content in circulating blood and responds to
oxygen deprivation by releasing erythropoietin. The location of
these two renal functions is not known. However, since the renal
medulla is borderline hypoxic, it seems likely that the oxygen is
located in the medulla, and since the juxtaglomerular apparatus
has been incriminated in the production of both renin and erythro-
poietin, it seems likely that the cortex is responsible for erythro-
poietin release. If this is the case, the biogenesis of erythropoietin
would demand some kind of informational transfer from the oxy-
gen sensor to the erythropoietin producer, and it has been suggested
that this is accomplished by an "erythropoietin releasing factor."
Recent studies in our laboratories of isolated perfused kidneys
have failed to support this suggestion, and it appears that the
cellular system which senses oxygen also releases erythropoietin.
This system is apparently not affected by factors from other or-
gans, since the isolated perfused kidney can synthesize erythropoie-
tin in the complete absence of blood or plasma. However, it does
demand that the perfusates have a certain viscosity since only
viscus artificial perfusion medias can initiate erythropoietin pro-
duction in isolated normal kidney. It is the hope that further
elucidation of this challenging process of oxygen sensing and erythro-
poietin production will lead to a much needed mass production
of erythropoietin for therapeutic use.
Anemia of chronic renal disease: II. Treatment. A. J. Erslev.
Department of Internal Medicine, Thomas Jefferson University,
Philadelphia, Pennsylvania. The amelioration of anemia of chronic
renal disease has become a major challenge since dialysis is now
keeping thousands of renal patients alive, but unfortunately, with-
out improving their chronic anemia and dependence on trans-
fusions. The therapeutic approaches can be listed as follows: I)
transfusion with packed or frozen red cells, 2) intensive dialysis, 3)
eliminate exposure to oxidant drugs and water purifiers, 4) iron
supplement, 5) splenectomy, 6) stimulate endogenous eryth-
ropoietin production (androgens), 7) activate extrarenal eryth-
ropoietin production, 8) replacement therapy with erythropoietin.
These approaches will be discussed and evaluated.
Effect of diphosphonate on ectopic calcifications in chronic hemo-
dialysis patients. L. Fabbri, M. Fusaroli, and P. Zucchelli. Depart-
ment of Nephrology and Dialysis, Malpighi Hospital, Bologna, Italy.
The effects of disodium ethane-l-hydroxy-l, I-diphosphonate
(EHDP), 7.5 to 15mg/kg of body wt per day, given orally for 5 to
6 months, have been studied in 3 patients on periodic hemodialytic
treatment for a period lasting from 3 to 6 yr, who were affected by
wide vascular and metastatic calcifications. All the patients were
submitted to serial investigations including roentgenologic exam-
ination of the skeleton with industrial film and screens at high
resolution, bone scanning with Tc-99m, bone densitometry, and
bone biopsy with evaluation of quantitative parameters. Results
were as follows: I) calcemia and phosphatemia have been kept
within normal range, alkaline phosphatase increased; 2) x-ray ex-
amination has revealed a clear and progressive improvement of
ectopic and vascular calcifIcations, while the skeletal lesions were
unchanged; 3) osteitis fibrosa worsened in one case and remained
unchanged in the others. The percentage of osteoid seam covered
with active osteoblasts increased without significant variations of
the calcification front.
Further proposals for the diagnosis of interstitial nephropathy due
to bacterial infection. E. Fiaschi, S. Favaro, L. Conventi, 0. Vernier,
B. Baggio, G. Martin, A. Antonello, A. Borsatti. Istituto di Clinica
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Medical, Università di Padova, Padova, Italy, and Is! ituto di Micro-
biologia, (]niversità di Padova, Padova, Italy. Correlations existing
between urinary tract infection and possible lesions of the renal
parenchyma are still uncertain. Any attempt toward clarification of
this problem must consider the precise site of the infection. Farley
et al have proposed collection of urine following bladder wash-out
with non-reabsorbable antibiotics as a diagnostic test to determine
infection site. This method, however, is tedious and not lacking in
risk for the patient. Recently, Thomas et al detected the presence of
immunoglobulins adherent to bacteria in urinary sediment by
means of direct immunoiluorescence technique. They suggested
that this finding is an index of bacterial persistence in the renal
parenchyma. This extremely simple technique could substitute
Farley's test for distinguishing the renal or nonrenal origin of
bacteriuria. We evaluated the reliability of this method in a group
of about 40 bacteriuric patients by comparing it with Farley's test
and other parameters of interstitial involvement (tubular protein-
uria, lysozyme and 'y GT urinary activities). We observed: I) a
highly significant correlation between Farley's test and the pres-
ence of antibody-coated bacteria; 2) a highly significant correlation
between presence of antibody-coated bacteria and interstitial in-
volvement; 3) a poorly significant correlation between these two
parameters and X-ray examination, as well as other tests, such as
leukocyturia and serum antibody titer.
Viability assays on twenty-four-hour preserved kidneys after dif-
ferent warm ischemia intervals. G. Garini, E. Ovaleo-Pandolfo, V.
Gaudiano, G. Olivetti. V. Cambi, and L. Migone. Clinica Medica II,
Università di Parma, Italy; Istituto di Patologia Chirurgica, Univer-
sità di Parma, Italy; Istiluto di Anatomia Patologica. Università di
Parma, Italy. In order to define reliable criteria for assessing the
viability of the kidneys, eight dog kidneys were preserved for 24 hr
by continuous hypothermic perfusion (Gambro machine) with
human albumin (Kabi, Boeringher) as perfusion medium. Prior to
preservation, the kidneys were subjected to warm ischemia inter-
vals varying from 0 to 60 mm. All were transplanted after 24 hr-
perfusion into the neck of donor animals. Posttransplant function
of kidneys was assessed by BUN and serum-creatinine determina-
tions. During preservation, samples were regularly taken from the
perfusate, and the lactate and lactic-dehydrogenase (LDH) con-
centrations were measured. In addition, the pressure, flow, and
perfusate pH were checked. Before and after perfusion the kidney
weight was measured. In kidneys preserved without warm ischemia
there was only slight LDH release, small increase in lactate produc-
tion, and immediate posttransplant function. Subsequent histology
showed no evidence of injury. Kidneys preserved after 60 mm of
warm ischemia did not function because of acute tubular necrosis.
In this group, lactate production and LDH release were correlated
to the degree of renal damage. In both groups there was a small
weight gain, a rise in perfusate pH (because of CO2 loss through
the perfusion Set) and no increase of perfusion pressure. It is
concluded that measurement of lactate production and LDH re-
lease, in conjunction with perfusion characteristics, are useful
means to predict the kidney viability prior to transplantation.
Digitalis therapy on hemodialysis. A. Giangrande, P. Al/aria,
Payola Canti, and A. Limido. Renal Unit, Busto A rsizio Hospital,
Italy. A systematic, noninvasive evaluation of systolic time inter-
vals obtained during hemodialysis and after the acute overload
given by the reinfusion, in 19 chronic uremic patients on dialysis
treatment of 5 hr/3 times per week which was over a period of 6 to
73 months, allowed us to identify 5 patients (25%) whose pattern
was indicative of impaired ventricular function [remarkable in-
crease in the pre-ejection period (PEP), reduction of ejection frac-
tion (EF)1. The setting-up of digoxin maintenance therapy (0.125
mg, 3 to 4 days a week) has been followed by radioimmunologic
serum digoxin assays, which brought us to verify the achievement
of pharmacologically active rates (1.1 to 2.2 mg/mI) between the
15th and the 30th day of treatment. The repeated recording over
digoxin therapy has proved the achievement of a beneficial clinical
response (PEP and EF improved). On the other hand, such uni-
vocal correlation was not always achieved through the serum di-
goxin rates, which even on this occasion seemed to be a rather
unreliable index of therapy. The side effects due to intradialytic
potassium unbalance were easily counteracted by KCI infusion.
Therefore, a close evaluation of ventricular function of the uremic
patients seems to suggest digitalis therapy as being more reliable
than it has been considered so far.
Histidine and anemia of patients with chronic renal failure. C.
Giordano. Chair of Nephrology, 1st Medical Faculty, University of
Naples, Nap/es, Italy. In the last ten years we have investigated
histidine metabolism in uremia and have obtained the following
information: 1) low plasma levels of this amino acid (1966): 2)
small extent of 15N incorporation into histidine in isotopic experi-
ments (1968); 3) histidine supplement to the diet resulting in in-
creased globin synthesis (1968, 1970, 1972); 4) increased hemato-
crits in dialyzed patients receiving histidine supplementation (1973,
1974). During the last year we have performed the following study
in order to evaluate the effects of histidine and iron supplementa-
tion on the anemia of 12 patients on conservative management for
chronic renal failure (GFR below 10 ml). The following protocol
was designed: period A, control; period B, 250 mg iron as iron-
dextran i.m./month; period C, 300 mg of histidine 3 times a day per
os at meal time; period D, patients received histidine associated to
iron. Each period lasted 3 months. Hematocrit was 22.1 + 0.7 vol
% in A; 23.3 + 1.7 in B; 28.3 + 0.9 in C, and 29.6 + 1.4 in D.
Statistical analysis revealed significant differences for: C and D vs.
A and B, and for C vs. D. Transferrin levels were 160 + 16 mg/dl
in A; 167 + 8 in B; 220 + 17 in C; and 218 + 13 in D. Statistical
analysis showed significant differences for C and D vs. A and B.
Data presented show that iron per se is not able to affect anemia of
renal failure, which in turn is greatly affected by the association of
iron to histidine. These data are in good keeping with those of
Johntofson et al (1975) in-so-far as the additive action of iron and
histidine is concerned, but our data differ in that they do not
furnish evidence for a beneficial action of iron alone. The under-
lying mechanism for the data presented should be found in: the
amelioration of nutritional status, the composition of globin which
is rich in histidine, the nature of the link between heme and globmn
and, possibly, enhanced gastrointestinal adsorption of iron me-
diated by histidine.
Toxic factors in the genesis of the uremic anemia. S. Giovannetti.
Università di Pisa, Pisa, Italy. The hemolyzing effect of uremic
serum was demonstrated by the observation that erythrocytes from
uremics had a longer life span than those of the same uremic
patients. Conversely, normal erythrocytes had a shorter survival
when transfused to uremics. Likewise, the rate of the in vitro
spontaneous autohemolysis of normal erythrocytes was higher
than that of the same red cells incubated in normal serum. Methyl-
guanidine and creatinine added to normal sera increased the rate
of autohemolysis, and when injected to normal dogs, reduced their
red cell survival. The inhibition of red cell production induced by
the uremic intoxication was shown by the impaired growth of bone
marrow culture incubated with uremic serum, and the same effect
was found to be exerted by normal serum with added methyl-
guanidmne and creatinine. Experiments carried out on normal
dogs showed that methylguanidine intoxication caused an impair-
ment of the iron turnover and a rapid decrease of red cell mass.
Finally, the uremic intoxication may cause anemia through the
hemorrhages caused by the bleeding tendency that it produces. The
role of the uremic intoxication in the genesis of the uremic anemia
is clearly demonstrated by the improvement that can be obtained
with the repeated dialysis, provided they are correctly made.
Total parenteral nutrition in chronic uremia. G. F. Guarnieri. L.
Faccini, R. Carretta, L. Campanacci. P. Lucchetti, G. Mustacchi, R.
Apo/lonia, G. F. Monti, G. Ago/mi. Istituto di Patologia Medica,
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Università di Trieste, Istituto di Clinica Chirurgica, tiniversità di
Trieste, Sezione di Farmacologia Clinica, Laboratori Don Baxter,
Trieste. Diet therapy is still important for the treatment of chronic
uremic patients, both dialyzed and undialyzed. Patients with
chronic renal failure are often catabolic and in negative nitrogen
balance, and have been shown to be affected by disorders of
glucose, lipid, and protein metabolism which are not normalized
by renal dialysis therapy (RDT). In three selected chronic uremic
patients we administered by central venous catheter a mixture of
glucose (70 g/l00 ml), essential amino acids plus histidine (Fre-
amine E, 15 to 40mg N/kg of body wt per day), minerals, vitamins,
and insulin for 17 to 19 to 35 days. Caloric intake varied between
28 and 51 kcal/kg/day. Corrected nitrogen balance became posi-
tive with higher caloric intakes, and serum urea nitrogen markedly
decreased. Serum proteins (e.g. transferrin) increased. Thrombo-
elastogram and platelet aggregation became normal. Motor nerve
conduction did not vary uniformly. An increase of serum triglycer-
ides was observed only in one patient, while blood lactate varia-
tions were very limited. An improvement of general conditions was
always observed. From these results it can be concluded that with
parenteral hyperalimentation a positive nitrogen balance may be
achieved in chronic uremic patients with only 15 to 20 mg N/kg
of body wt per day, provided that an adequate caloric supply is
administered.
Anemia of children with chronic renal failure. R. Gusmano, F.
Perfumo, and G. Basile. Nephrology and Dialysis Section, G. Gaslini
Institute, Genoa. Italy. Uremia is almost invariably accompanied
by anemia. In adulthood the dialytic treatment determines an
improvement of anemia; in pediatrics the Hct is lower, between
13% and 18%; in our patients the average is 14.9%. The aim of this
study is to evaluate the reasons of the persistence of the anemia in
the uremic children. We evaluated: I) red cell life span; 2) ferro-
kinetics; 3) blood loss by and with hemodialysis; 4) relations with
age, nephropathy causing renal failure, length of dialysis and dialy-
tic scheme; 5) influence of various policy of transfusions; 6) nutri-
tional status of patients and effect of iron and vitamin supplemen-
tation. From our data, based on 60 patients, aged 4 to 14 at the
start of dialysis, treated from 3 to 78 months, the "unphysiology"
of dialysis with the present system can be sustained. The following
points can be remarked: a) anemia worsens in the first months of
dialysis; b) ferrokinetics and red cell life span remain abnormal in
the majority of cases; c) start of more frequent dialysis has not
caused an improvement of anemia; d) iron supplementation is
useful only to maintain a balance with the losses; e) nutritional
status is not always correlated with anemia. We emphasize that
blood loss with the present system of dialysis is too large for a child
and that the use of new dialytic devices, allowing a minor blood
loss, could be a primary point to obtain an improvement of anemia
in dialyzed children.
Uremic pericarditis in childhood: Treatment and prognosis. R.
Gusmano, F. Perfumo, L. Formicucci, and A. Bertolini. Nephrology
and Hemodialysis Section, Department of Vascular Surgery, G.
Gaslini Institute, Genoa, Italy. Six patients, aged 4 to 14, in renal
dialysis therapy have shown pericarditis. The incidence is 10% of
overall cases treated and between 10 to 15% in dialyzed adults. In
five out of six cases, pericarditis appeared one to three months after
the start of dialysis treatment. Age and weight of patients were not
different from other dialyzed children. Predialysis urea, creatinine,
calcium, phosphate, alkaline phosphatase, and hematocrit were
also similar. Fever and thoracic pain were the most, prominent
clinical signs. For diagnostic purposes teleradiogram and determi-
nation of central venous pressure were helpful, but rarely ECG
showed pathological changes. More frequent dialysis, up to daily
dialysis, was the principal treatment. With this therapy, three cases
recovered. In three cases, pericarditis worsened and surgical drain-
age was required for resolution of the tamponade. All cases even-
tually recovered. The pathogenetic hypothesis and the diagnostic
and therapeutic problems are discussed. It is emphasized that in
the presence of a conspicuous pericardial hemorragic effusion early
pericardial drainage is the treatment of choice.
Surgical treatment in renal vein thrombosis with nephrotic syn-
drome. A. L'Abbate, C. Zoccali, M. Biagini, C. Bellinvia, R. Mazzi-
telli, A. Vegeto, F. De Maio, and Q. Maggiore. Centro Fisiologia
Clinica C.N.R., Divisione Nefrologica "G. Monasterio," 'Ospedali
Riuniti, Reggio Calabria. Italy. 1 Clinica Chirurgica, Milano, Italy.
It is not known if the renal vein thrombosis is the cause or a
complication of the nephrotic syndrome. In an attempt to clarify
this problem, the effect of venous thrombectomy on the course of
the nephrotic syndrome was studied. Renal vein thrombectomy
was performed in two patients. One patient, who presented epi-
sodes of thrombophlebitis of the legs and two bouts of pulmonary
embolism that apparently preceded the Onset of nephrotic syn-
drome, had extensive thrombosis of vena cava extending into both
renal veins. The other patient showed, on selective renal arteri-
ography, a right renal vein thrombosis as an unexpected finding.
Renal biopsy showed a membranous glomerulonephritis affecting
both kidneys. Both patients were submitted to thrombectomy
which restored normal patency of renal venous effluents, as docu-
mented by angiographic studies. After surgery, patients received
long-term oral anticoagulant therapy. However, nephrotic syn-
drome was not apparently influenced by successful venous recanal-
ization in the two months of postoperative follow-up. It is con-
cluded that renal venous thrombectomy does not influence the
nephrotic syndrome on the short term.
Hormonal factors and uremic anemia. S. Lamperi. P. Fiorio.
Division of Nephrology and Dialysis, Ospedali Civili di Genova,
Genoa, Italy. At present, erythropoietin (Ep) abnormalities are felt
to be major contributory factors to the pathogenesis of renal
anemia. This study aims at evaluating such a possibility, measuring
serum and urinary Ep both in subjects with chronic renal failure
(CRF) in the course of different therapies and in control of anemic
patients by the hemaglutination-inhibition (HA!) method. Our
data have shown the constant presence of Ep in the serum and
urine of the patients under study. Patients on conservative therapy
and after renal transplantation have shown values above normal,
while dialyzed uremics had normal Ep levels. Serum and urinary
Ep values found in uremics on conservative therapy and in trans-
planted uremics, although well above normal, do not reach those
found in control anemic patients, hematocrit being equal. We
administered to anemic patients with CRF a substance containing
EP, which was obtained, according to Lowy and Borsook's tech-
nique, from large amounts of urine of posthemorrhagic anemic
subjects. Serum and urinary Ep levels, as well as hematic parame-
ters, increased during the administration. These data seem to con-
firm that Ep and uremic marrow cells are only partially capable to
interact, so that high urinary Ep levels could mean a loss of it for
deficient uptake. It follows that constant and massive doses of Ep
might be necessary to reduce uremic marrow inactivity. Never-
theless, the presence of an inhibitor able to inactivate or prevent Ep
uptake cannot be excluded.
Glucose-6phosphate dehydrogenase (G6PD) and pyruvate kinase
(PK) in the erythrocytes of uremic patients on chronic dialysis: A
contribution to the study of uremic anemia. E. Lusvarghi, A. Sgan-
durra, G. Malmusi. Cattedra di Nefrologia Medica deli' Universitb,
Policlinico, Modena, Italy. Twenty-eight patients with chronic
renal failure on high-flux hemodialytic treatment (three times
weekly) were studied for their erythrocyte G6PD and PK activity.
Of the 28 patients examined during predialytic stage, 26 had nor-
mal values. Red cell metabolism returns to normal during ade-
quate hemodialytic treatment. We support that there is no evidence
of an intraglobular factor associated to the well known extra-
globular factor in the mechanism which induces hemolysis in the
anemia of uremic patients.
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Platelet kinetics in chronic renal failure. E. Lusvarghi and
G. Curci. Catiedra di Nefrologia Medica, Università degli Studi di
Modena. In 19 uremic patients in conservative treatment with GFR
ranging between 15 and 30 ml/min/1.73 m2 BSA, the following
tests were performed: 1) platelet lifespan measured with 51Cr; 2)
platelet aggregation (PAT) evaluated by the Breddin test; and 3)
urinary fibrinogen degradation products (FDP). The results ob-
tained demonstrate: a) in uremia the average lifespan of platelets is
reduced: 5.95 + 0.75 as compared to a normal value of 8 + I days;
b) this reduction is presumably in relation to excessive peripheral
platelet consumption; c) in chronic uremia the PAT, studied by the
Breddin test, is increased; the presence in all patients of hyperten.
sion prevents the possibility of an objective interpretation of this
phenomenon; d) there are no significant correlations between the
level of urinary FDP, urea, creatinine plasma values, the value of
GFR, and the average lifespan of platelets.
Variations of splay and maximal reabsorptive capacity of P04
(TmPO, and TmPO4/GFR) during extracellular volume expansion
(ECVE) in patients with chronic glomerular kidney disease.
G. Mioni, L. Cristine/li, P. Messa, G. Cannella, G. Panzetta, A.
D'Angelo, N. Tessitore. Divisione di Nefrologia, Spedali Civili di
Brescia, Italy; Prima Clinica Medica, Università di Padova, Pa-
dova. Italy. In ten patients with GFR ranging from 80 to 120
mI/mm and from 10 to 30 mI/mm, Bijvoet's nomogram has been
used to calculate the TmPO4/GFR(STc) in basic conditions, after
ECVE and during P04 titration curves, until the attainment of the
TmPO4. With the experimental TmPO4/GFR (STexp), so ob-
tained, the ratio of STe to STexp has been calculated (STc/STexp)
for the various experimental conditions. The splay of P04 titration
curves has been factored by GFR and Tm and analyzed. With
regard to results the following is to be noted: 1) in the uremic
patients UVPO4/GFR is higher than that in the near-normal GFR
subjects, both before and after ECVE; 2) only in these latter ones
can ECVE increase UVPO4/GFR significantly; 3) the titration
splay is widened by ECVE disproportionately to the Tm/GFR,
both calculated and experimentally obtained; 4) while the STexp is
held constant during the PU4 infusion, the STe increases so that
the STc/STexp ratio, from values less than I after ECVE, attains
unity during P04 infusion, in spite of persistence of ECVE. From a
practical point of view, Bijvoet's nomogram, which does not take
into account ECVE, is not adequate to obtain the TmPO4/GFR as
an index of PTH hypersecretion in uremic patients owing to their
basic ECVE.
Glomerular cell proliferation in experimental immune-complex
glomerulonephritis: Light, electron microscopic and autoradiographic
investigations. G. Monga, 0. Campobasso, Maria G. Canese, G.
Palestro. and F. Mo/b. Istituto di Anatomia e Isto/ogia Patologica,
Centro di Microscopia Eiettronica, Università di Torino, Italy. Gb-
merular cell mitoses have occasionally been observed in both hu-
man and experimental proliferative glomerulonephritis, but the
nature of dividing cells still remains obscure. Light and electron
microscopic and autohistoradiographic investigations have been
undertaken in order to achieve further information on this prob-
lem. An immune complex gtomerulonephritis has been induced in
rats. One hundred to 120 glomeruli on sections from paraffin.
embedded kidneys were examined in each rat (both control and
nephritic ones). The overall number of glomerular cells, the num-
ber of labelled nuclei and of mitoses were counted. The mitotic and
labelling indices were then obtained. The difference in labelling and
mitotic indices between treated and control animals were statist-
ically significant (P < 0.0001). All dividing cells in electron micro-
scopy appeared directly facing the capillary lumina and showed the
presence of junctional complexes with neighboring endothelial
cells. Our data indicate that at least in this experimental model of
.glomerulonephritis the dividing cells should be interpreted as en-
dothelial. Further investigations with autoradiographic methods at
the electron microscopic level are in progress on this topic.
Intracellular sodium, potassium and water in chronic renal failure
(CRF): Comparative studies on leukocytes and muscle. A. Mon-
tanari, L. Borg/it, G. Bruschi, M. Canali, A. Novarini, and A. Bor-
ghetti. Istituto di Semeiotica Medico deli' Universith di Parma,
Parma, Italy. In the present work, we report comparative studies
on water, sodium, and potassium content of the skeletal muscle
obtained by needle biopsy, and of the leukocytes separated from
peripheral blood in 18 subjects (6 controls and 12 with CRF). Our
data are in agreement with those previously reported: sodium and
water increase and potassium depletion both in muscle and leu-
kocytes are found in CRF. A highly significant correlation is found
between leukocytes and muscle potassium under basal conditions,
i.e., without acute potassium unbalances. When potassium reple-
tion is reached in a period of 10 to 15 days, a good agreement
between muscle and leukocyte ptassium increase is found. The
leukocyte content less closely reflects acute changes of potassium
balance; when an acute potassium depletion or repletion were
induced, no significant variation was found in leukocyte potas-
sium, while muscle potassium underwent wider changes.
Kidney transplantation: Results in 150 patients. C. Ponticelli,
G. Banfi, D. Brancaccio, A. Cantaluppi, N. Case, A. De Vecchi,
G. Graziani, L. Guerra, E. Irnbasciati, 0. Maestri, E. Rivoita, and
A. Tarantino. Divisione di Nefrologi e Dialisi, Padiglione Croff Pouch-
nico, Milano, Italy. Over a period of 7 years, in 150 patients, 154
kidney transplants were performed: 141 from cadaver and 13 from
living related donors. Actuarial patient survival rate was 83 percent
at 1 year and 78 percent at 7 years. The graft actuarial survival was
56 percent at 1 year and 43 percent at 7 years. In our experience,
patient survival can be enhanced by: a) careful recipient selection;
b) low toxicity steroid administration schedule, as daily or on
alternate-day morning administration; c) avoiding overdiagnosis
of rejection; d) avoiding prolonged high dose steroid administra-
tion during acute rejection; e) prompt return of the patient to
dialysis in case of unsuccessful graft. By these criteria a further
decrease of death rate after transplantation can be obtained. A
mortality rate, as low as with regular dialytic treatment, allows us
to consider renal transplantation as an elective procedure in the
therapy of end-stage renal failure.
Persistent urinary tract infection in childhood. F. Perfumo, M. B.
Ciardi, C. Viscoh, M. Sarperi, and R. Gusmano. Nephroiogy and
Hemodialysis Section, G. Gas/mi Institute, Genoa, Italy. The prob-
lems of urinary tract infection have been the object of numerous
studies, but have not been completely clarified. In this study, the
data of 178 patients affected by urinary tract infection, and ob-
served in our department fof the last 5 years, are presented. The
age of the patients varied from 15 days to 11 years. Newborn
children and patients in pubertal age are excluded. The urinary
tract infection was establishedby clinical and quantitative bacte.
riology on at least two different occasions. In all cases studies of
renal function and evaluation of some parameters—Hb, elec-
trolytes, bicarbonates, alkaline phosphatase, wrist radiogram, in-
travenous pyelography and micturating cystourethrography—were
carried out. In selected cases a more complete study of renal
function has been carried out by radioisotopic methods (renogram,
renal scan, RBF, GFR). The distribution of cases for age shows
some difference from data previously published. A typical bacteria
in males and E. coli in females are more frequently identified. In
infancy, male to female ratio is I: I, but afterwards the infection
prevails in girls with a 2: 1 ratio. The other biological parameters
have been correlated with height, weight and bone age to evaluate
the effect on growth of persistent urinary tract infection. Radio-
logical investigations showed a normal urinary tract in only 40.5%
of cases; in the others, major or minor abnormalities have been
observed. The need of early screening of urinary tract infection for
the prevention of progressive renal damage is emphasized.
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Sodium dialysate concentration. B. Rendaelli, S. Sforzini, D. Li-
mido, R. Mimmo, G. Di Filippo, P. DAmico, M. G. Grassi Prina.
Nephrology and Haemodialysis Service and Nuclear Medicine Serv-
ice, General Hospital, Monza, Italy. In an attempt to prevent the
immediate and long-term effects due to osmotic unbalances arising
from dialysis, 21 clinically stabilized uremic patients, dialyzed over
a period of at least one year against a dialysate containing a mean
sodium concentration of 133 mEq/liter, were then dialyzed over a
period of at least one year against a mean sodium dialysate concen-
tration of 143 mEq/liter. Predialytic mean arterial pressure (MAP)
were found to be lower. During each dialysis the total body water
loss increased (P < 0.02) without a statistically significant decrease
of predialytic plasma volume and blood volume. Predialytic os-
molarity and sodium serum water concentration increased (P <
0.01 and P < 0.005) and their intradialytic variations decreased (P
< 0.02 and P < 0.001). Hct increased (P < 0.05), IGTT and
endogenous insulin sensibility significantly improved. Intra- and
post-dialytic asthenia, headache, and cramps decreased in fre-
quency.
Dialysis and transplantation in childhood. G. Rizzoni, G. Zac-
chello, L. Pavenello, I. Marella, T. Basso, and F. Zacchelio. Pediat-
ric Department of the University, Padua, Italy. Between September,
1973 and March, 1976, ten children (5 to 13 years old) underwent
maintenance hemodialysis for a period of 3 to 18 months. All
children had been dialyzed for an average of 18 hours a week. No
death or major complications occurred. Physical rehabilitation was
satisfactory in all children and a normal school activity reestab-
lished in nine. Osteodystrophy lesions were evident in two cases,
but were completely healed during the course of the hemodialysis.
Five children never received transfusions and none has been trans-
fused during the last 12 months. Caloric intake was more than 75%
of the recommended requirement in nine children. In seven chil-
dren dialyzed for more than six months, the growth rate was above
normal in one, normal in two, and abnormal in the remaining four
subjects. Seven children underwent renal transplantation (two
from living and five from cadaver donors) in Louvain (Prof. Alex-
andre) after 3 to 18 months of dialysis. In one case the graft was
immediately rejected. Five children have a normal creatinine clear-
ance 3 to 22 months after transplantation. In one case the plasma
creatinine is 1.3 mg/lOO ml. Maintenance hemodialysis is a valid
treatment for terminal renal failure in children, provided that it is
followed as soon as possible by renal transplantation.
In vivo esaluation of eight dialyzers. E. Rossi, L. Ar/si, L. Big-
nardi, F. Bonuomo, G. Garini, G. Malmusi, G. Savazzi, V. Cambi,
and L. Migone. C/mica Medico II, Università di Parma, Parma,
Italy. Eight dialyzers have been evaluated in vivo on a group of
13 patients. Sixteen dialyses of 3 hrs' duration were performed on
each patient (2 dialysis treatments for each filter). Q5 = 250, Qo =
500 mI/mm. Dialyzer characteristics: 6 coils, 2 parallel flows, sur-
face areas from 1.0 to 1.5 m2. At the beginning of treatment, after I
and 3 hrs and 1 hr after the end, the following parameters have
been evaluated: arterial and venous concentration of urea (U),
creatinine (C), uric acid (UA), and phosphates (P). According to
the surface areas, clearances and % reduction of solute blood levels
correspond to the current data of the literature. One hour after the
end of the short dialysis period, the mean % increase of the blood
concentration of P (3 1%) is significantly higher than the rebound
concentration of U (8%), C (13%), and UA (13%). The prevailing
intracellular distribution of P may explain the higher rebound of
this solute in comparison to U and C homogeneously distributed in
the body compartments.
Thyro-adeno-lymphography in 30 uremic patients. R. Rossi. A.
Farma, G. C. Cairo/i, G. Casartelli, M. I. Quarenghi, M. Bassi, F.
Muggli, and G. Co/antonio. Sezione di Nefrologia, Ospedale S.
Anna, Como, Italy. Thyroid lymphography has been performed in
30 uremic patients according to the technique of Tomoyuki et al in
order to evaluate its suitability in localizing hyperplastic para-
thyroids. In 80 per cent of the cases, the technique showed
hyperplastic parathyroids of different sizes. Three patients under-
went surgery, which confirmed the radiological localization.
The 20% failures were due to difficulty in injecting the contrast
medium because of the anatomical position. In some few cases the
contrast medium was spread in the mediastinum without any con-
sequence for the patients. The data obtained confirm the value of
this technique which is simple to perform and has no risk for the
patient; furthermore, it is evident that it plays a definite role in
localizing hyperplastic glands before surgery.
Lupus nephritis: Clinical course in relation to treatment. M. Sas-
del/i, L. Cagnoli, P. Candi, S. Casanova, G. Pizza, and C. Rovinetti.
Department of Nephrology and Dialysis, Malpighi Hospital, Bo-
logna, Italy. Fourteen patients with active lupus nephritis were
studied in order to determine if there were specific correlations
between the clinical findings, the histological lesions, the immu-
nological parameters and therapy. In these patients, followed-up
for I to 12 years, 19 renal biopsies were performed and examined
by light and electron microscopy and immunofluorescence; the
histological pattern at the first control showed a diffuse pro-
liferative glomerulonephritis in 9 cases, a membranous glomerulo-
nephritis in 4 cases, and a focal proliferative glomerulonephritis in
I case. Renal function and immunological parameters (including T
and B lymphocytes) were monitored. All patients were treated with
daily high-dose prednisone associated in some cases to cytotoxic
drugs; in 5 cases irresponsive to this therapy, thoracic duct drain-
age was performed to improve the immunosuppression.
Kinetics of glomerular deposition of immune complexes in rabbit
acute serum sickness. G. Segoloni, G. Camussi, R. Ragni, P. Stratta,
G. Piccoli, and A. Vercellone. Cattedra di Nafrologia Medico della
Università di Torino, Divisioni di Nefrologia e Dial/si, Ospedale
Maggiore di San Giovanni Bauista e della Città di Torino, Torino,
Italy. We have studied the kinetics of glomerular and vascular
localization of immune complexes through serial renal biopsies
and analyzed the behavior of basophils in 20 rabbits, which were
given a single iv. injection of 500 mg of BSA. A reduction of the
total number of basophils has been noticed in the days directly
preceding the first glomerular deposits, The antigen represented by
BSA is seen to deposit precociously (7th to 8th day) in the sub-
endothelial-mesangial region of glomeruli, even in the absence of
immune globulins; it is progressively masked between the 10th to
12th day by gamma globulins deposition, and the location becomes
subepithelial. Positivity for C3 is seen later, and it persists alone in
the 14th to 15th day in the form of globular humps which tend to
join subsequently. We consider the hypothesis of IgE-dependent
initial vasopermeating action towards: 1) the precocious local-
ization of complexes, which do not fix the complement, in great
excess of antigen; 2) the local assembly of complexes in the region
of glomerular deposits; 3) the local fixation of complement. These
observations would confirm, in rabbit acute serum sickness, the
hypothesis formulated by Lange and Treser for human acute
glomerulonephritis.
Trial of indomethacin versus aspirin in rats affected with nephro-
toxic serum nephritis. A. Sessa, C. Bianchi, A. Cioffi, M. Colombi,
F. Conte, A. Di Ruscio, A. Durante, M. Saruggia, and C. Schmid.
Sezione di Nefrologia, Ospedale di Vimercate e Ospedale Maggiore
di Milano. C'entro di Citfarmacologia del CNR, Instituto di Era-
macologia dell'Università di Milano, Milano, Italy. In order to
demonstrate that the antiproteinuric effect of indomethacin is dis-
joined from its antiinflammatory one, we have performed a trial of
indomethacin vs. aspirin in rats made nephritics by inoculation of
nephrotoxic serum. Data will be provided indicating that the ef-
fects of proteinuria are due to diminished permeability of the
basement membrane, which in turn is due to increased podocytic
synthesis as demonstrated by morphologic data.
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Dietetic assistance to children undergoing chronic hemodialytic
treatment. M. Setari and A. Dalla Dea. Dietetic Service, Paediatric
Clinic, University of Padova, Padova, Italy. Ten children under-
going chronic hemodialytic treatment were kept under observation
in the course of 2½ years. The control period varied from 3 to 18
months. The analysis of food consumption was made on the basis
of a daily registration of the quantities and qualities of the food
ingested at home, direct observation of the children during dialysis,
and conversation with their mothers. The results showed a satisfac-
tory compliance with the prescribed diets as regards proteins: the
total average protein supply was 97% of the prescribed amount (70
to 125%), whereas the percentage of proteins of animal origin, as
compared with the total amount, was below the prescribed level
(about 62%). Compared with that recommended in the 1968 "Rec-
ommended Daily Allowances, National Research Council" for
children of the same age and stature, the caloric supply was 83%
(63 to 103%) on the average. No child received artificial caloric
integration. Artificial integration of an inadequate caloric supply
for longer periods is, for the time being, a problem of difficult
solution in pediatric age, but it must be investigated thoroughly.
The dietician's intervention has the purpose of eliminating the
"diet problem" from the child's experience as much as possible;
therefore, it should be particularly directed to the mother, with the
object of informing and training her so as to reassure her and
consequently enable her to manage her child's diet autonomously.
Serum complement and essential mixed cryoglobulinemia. A. Ta-
ran lino, L. Guerra, A. A nd/i, C. Ponticelli. Department of Ne-
ophrology, Policlinic Hospital, Milan Italy. In 21 essential mixed
cryoglobulinemic glomerulonephritis, serum complement hemoly-
tic activity (CH55) and Cl9, Cl5, C4, C3, CS, C9, C3A, Cl INA
complement components were serially determined for 3 to 32
months. The mean values were: CH50, 18 + 18 UE/ml (normal
range, 40 + 10 UE/ml); Cl5, 54 + 21% (99 + 14%); C]5, 60 35%
(95 + 22%); C4, 46 + 60% (100 34%); C3, 90 + 48% (100 +
26%); CS, 113 + 28% (91 + 19%); C9, 157 + 55% (92 24%); C3A,
102 35% (96 + 22%); Cl INA, 127 26% (100 + 16%).
Therefore the complement pattern in essential mixed cryoglobuli-
nemia is characterized by a depression of CH50, Cl9, Cl5, and C4
levels with C3, CS, C9, C3A normal values. In some serum samples
all complement components were decreased, but even in the cases
with low C3 levels, only rarely the C3A levels were depressed.
Therefore, the role of properdin system or of the amplification
loop of C3 does not seem to be important in the genesis of the
hypocomplementemia. In most cases, the levels of Cl9, Cl5 and
mainly C4 are persistently low, even if steroid or immunosuppres-
sive drugs are administered. This complement profile is very typical
and different from any other form of hypocomplementemic ne-
phritis.
New aspects of human kidney adaptation to metabolic acidosis.
A. Tizianello, G. Dc Ferrari, G. Garibotto, N. Acquarone, and
M. Bruzzone. Department of Internal Medicine, Chair of Medical Ne-
phrology, University of Genoa, Italy. Renal adaptation to metabolic
acidosis was studied in man by simultaneously measuring renal
ammonia production and renal extraction of glutamine and other
amino acids under normal acid-base balance and after one-, three-,
and 6-day NH4CI loads. In one-day acidosis ammonia production
increased by 50% (76 + 10.9 mole/min), whereas glutamine ex-
traction is significantly lower than in controls. Furthermore, in 3-
day acidosis, although glutamine extraction is increased; this
amino acid cannot account for about 25% of the ammonia pro-
duced. In these early phases, then, other substrates must produce
ammonia. In effect, we found that significant amounts of other
amino acids, mainly glycine, proline, and valine, are extracted by
the kidney. On the contrary, in 6-day acidosis, as in normal condi-
tions, the glutamine extracted can account for all ammonia pro-
duction and no extraction of other amino acids is observed. In
conclusion, as far as ammonia production is concerned, kidney
adaptation to metabolic acidosis goes through two phases: it is
only in the later phase that glutamine plays an important if not
exclusive role, whereas in the earlier phases this substrate is signifi-
cantly aided by glycine, proline, and valine.
Evaluation of acid-base balance in patients maintained with
chronic hemodialysis. C. Vancini, V. Mazzarella, D. Menicocci, M.
Taccone Gallucci, F. Mine/li, C. U. Casciani. Semeiotica Chirurgica
III, University of Rome, Italy and Gambro, Italy. The object of this
study is the evaluation of acid-base balance in two groups of
patients (23 to 21) treated by two different acetate dialysate con-
centrations (1st group, 38 mEq/liter; 2nd group, 35 mEq/liter).
The pre- and postdialysis determinations performed were 157. Re-
sults: postdialysis values indicated a [HCO3-} and pCO2 increase
together with a pH and BE increase for both groups. A pCO2
increase occurs in 72 pre- and postdialysis determinations out of 77
in the first group, but in the second group a pCO2 increase occurs
in 53 determinations out of 80. It is our opinion that this is due to
a better metabolic correction of the first group. Most of the 32 pre-
and postdialysis measurements, in which a pCO2 decrease occurs,
show a predialytic acid-base balance in the normal range. Linear
relationship between postdialysis pCO2 and a corresponding
[HCO3-] increase have been demonstrated. The conclusion of this
study is that postdialysis pCO2 increase is due to the metabolic
correction of acid-base balance and particularly to the [HCOa]
increase as a consequence of dialysis treatment. Another reason
may be a hypoventilation caused by postdialysis metabolic alka-
losis, according to Van Ypersele (1973).
Segmentary renal hypoplasia (the Ask-Upmark kidney): A study
of four cases. G. Zacche/lo, G. Rizzoni, F. Zacche/lo, F. Pagano,
G. Passerini, and F. Mantero. Paediatric Clinic and Paediatric
Urology Clinic, Medical Semeiotics Institute, University of Padova,
Padova, Italy. We report four cases of segmentary renal hypo-
plasia: three females and one male ranging in age from 8 to 13 yr.
One patient presented with symptoms of hypertension, while the
others were affected with urinary disturbances. All cases evidenced
chronic arterial hypertension with blood pressure levels between
130/90 and 180/120. Renal function was normal in three children
but reduced in the fourth subject. The urography and arteri-
ography both showed a characteristic picture: dilatation of the
calyces in correspondence with an incisure located on the external
border of the kidney and hypovascularization of the involved
areas. Micturition cystography evidenced vesico-ureteric reflux in
the two females with history of urinary infections. The radiological
findings and the renin levels in the renal veins led to the diagnosis
of monolateral segmentary hypoplasia in two cases and to that of a
bilateral and frankly asymmetric form in the remaining patients.
The most severely affected kidneys in this latter group were almost
nonfunctioning. Nephrectomy was carried out on all subjects, and
this was associated in two cases with reimplant of the controlateral
ureter. Complete normalization of the blood pressure was obtained
after surgery in the two cases with monolateral hypoplasia, while a
temporary, partial control was observed in the others. Histologic
examination of the kidney revealed the characteristic pattern of
alternating zones of normal parenchyma with areas of hypoplasia
in both the cortex and medulla. The most important histopatho-
logic alterations, essential for making a differential diagnosis with
chronic pyelonephritis, are represented by the paucity of in-
flammatory cells, the large amounts of thyroid-like tissue, the
reduction or loss of the glomeruli, and by the magnitude of the
vascular changes. We stress the importance of segmentary hypo-
plasia as a cause of renovascular hypertension in childhood.
Propranolol in hyperreninemic malignant hypertension: A hemody-
namic study. C. Zoccali, G. Monzani, S. Marenghini, and Q. Mag-
giore. Centro Fisiologia C/mica C. N.R., Divisione Nefrologica "G.
Monasterio," Ospedali Riuniti, Reggio Calabria, Italy. The study
was aimed to assess the hemodynamic mechanism of the hypoten-
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siveeffect of propranolol in high-renin malignant hypertension and
in normal renin hypertension. Eight patients with high PRA (7.9 +
2.6 ng/ml/hr) and six patients with normal PRA (1.6 + 1.0
ng/ml/hr) were studied. Four patients in the first group were on
chronic hemodialysis. Propranolol dosage was 240 to 280 mg/day
by mouth. The hemodynamic study was performed by the Selective
Quantitative Radiocardiography before and one month after start-
ing the pharmacological treatment. Propranolol produced a signif-
icant fall in mean blood pressure (P < 0.0025), cardiac rate (P <
A bstracts
0.025), and PRA (P < 0.005). Cardiac output, which was signifi-
cantly reduced (P < 0.025) in the control period, increased with
treatment by 13.8%; peripheral vascular resistances decreased by
18.0%. even though not to the normal range. The hypotensive effect
was not related to the hyporeninemic effect (r = 0.48; P < 0.1).
Comparable hemodynamic effects were observed in normoreni-
nemic patients, but there was significant change in PRA levels. We
conclude that the hypotensive activity of propranolol is not related
to its hyporeninemic effect.
